PRAX Stock Analysis: Buy, Sell, or Hold?
PRAX - Praxis Precision Medicines, Inc. Common Stock
$276.38
-13.73 (-4.73%)
▼
5d:
-6.03%
30d:
-17.93%
90d:
+2.76%
HOLD
LOW Confidence
Analysis Updated: Mar 30, 2026 12:00 AM ET
Earnings: May 01, 2026
Smart Money Accumulation
PRAX is down 5.0% this week, but smart money is accumulating calls. Top strike: $350 2026-04-17 with 13 OI. Call ratio: 100% View Scanner →
Strength: 7.5/10
Get Alerted When PRAX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: PRAX shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: PRAX shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: PRAX is currently trading at $276.38, which is considered oversold relative to its 30-day fair value range of $293.35 to $331.51.
Technical Outlook: Technically, PRAX is in a strong uptrend. The price is currently testing key support at $282.50. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 4.7% recently.
Market Sentiment: PRAX has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $617.62 (+112.9%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, PRAX is in a strong uptrend. The price is currently testing key support at $282.50. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 4.7% recently.
Market Sentiment: PRAX has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $617.62 (+112.9%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$293.35 -
$331.51
Company Quality Score
56/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
62.5%
Protect Your Profits
Holding PRAX? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Options cheap (IV 0th percentile)
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-4.7%)
- BULLISH: Trading 112.9% below Wall St target ($617.62)
- CAUTION: Recommendation downgraded due to -6.0% 5-day decline
Fair Price Analysis
30-Day Fair Range
$293.35 -
$331.51
Current vs Fair Value
OVERSOLD
Expected Move (7 Days)
±$27.54
(10.0%)
Support & Resistance Levels
Support Level
$282.50
Resistance Level
$315.00
Current Trend
Strong Uptrend
Technical data as of
Mar 30, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-33.55
Wall Street Target
$617.63
(+112.9%)
Revenue Growth (YoY)
1349.1%
Share & Embed Analysis
Last updated: March 30, 2026 1:57 PM ET
Data refreshes hourly during market hours. Next update: 2:57 PM
Data refreshes hourly during market hours. Next update: 2:57 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is PRAX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
2
Sells
Net
INSIDERS SELLING
Recent Transactions
Alex Nemiroff
SELL
25130 shares
2025-11-20
Lauren Mastrocola
SELL
13600 shares
2025-11-20
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NTLA
Intellia Therapeutics Inc |
STRONG BUY
29 analysts |
$25 | 52 HOLD |
|
INSM
Insmed Inc |
STRONG BUY
19 analysts |
$213 | 67 BUY |
|
APLS
Apellis Pharmaceuticals … |
BUY
22 analysts |
$33 | 49 HOLD |
|
IMVT
Immunovant Inc |
STRONG BUY
14 analysts |
$40 | 57 HOLD |
|
GPCR
Structure Therapeutics I… |
STRONG BUY
14 analysts |
$109 | 45 HOLD |
Advanced PRAX Option Strategies
Professional options setups generated by AI based on today's PRAX price and gamma walls.
